Oral lesions in a group of kidney transplant patients;Lesiones bucales en un grupo de pacientes con trasplante renal

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 10, Issue 3, 2005, Pages 196-204

  De La Rosa García, Estela ^a,c   Mondragón Padilla, Arnoldo ^b   Irigoyen Camacho, María Esther ^a   Bustamante Ramírez, Martha Alicia ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c NONE   (Mexico)

Author keywords

Cyclosporin A; Gingival hyperplasia; Kidney transplant; Oral mucosa lesions; Saburral tongue

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; CYCLOSPORIN A; ENALAPRIL; LOSARTAN; NIFEDIPINE; PREDNISONE; VERAPAMIL;

ADOLESCENT; ADULT; ARTICLE; DRUG BLOOD LEVEL; FEMALE; GINGIVA HYPERPLASIA; HERPES SIMPLEX; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LEUKOPLAKIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; MOUTH LESION; MOUTH MUCOSA; OUTPATIENT; PREVALENCE; THRUSH; TONGUE DISEASE;

ADOLESCENT; ADULT; CALCIUM CHANNEL BLOCKERS; CANDIDIASIS, ORAL; CYCLOSPORINE; FEMALE; GINGIVAL HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOPLAKIA, HAIRY; LOGISTIC MODELS; MALE; MIDDLE AGED; MOUTH DISEASES; NIFEDIPINE; ORAL HYGIENE; TONGUE;

EID: 18744364165     PISSN: 16984447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Centro Nacional de Transplantes en México. Online available at: http://www.rnt.gob.mxcenatra/estadistica/2004. Sponsored by Secretaria de Salud, Centro Nacional de Transplantes. June 8, 2004
2. Danovitch GM. Danovitch GM. Handbook of kidney transplantation. Philadelphia; Lippincott Williams & Wilkins. 2005.
3. U.S. Renal Data System, USRDS 2004 annual data report: Atlas of End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, Bethesda, MD, 2004. Available on line at: http://www.usrds.org/adr.htm
4. Matas AJ, Human A, Gillngham KJ, Payne WD, Gruessner RW, Kandaswamy R, et al. Five preventables causes of kidney graft loss in the 1990s; a single-center analysis. Kidney Int 2002;62:704-12.
5. Vincenti F. Immunosuppression minimization: Current and future trends in transplant immunosuppression. J Am Soc Nephrol 2003;14:1940-8.
6. Marshall RI, Bartold PM. Medication induced gingival overgrowth. Oral Dis 1998;4:130-51.
7. King GN, Healy CM, Glover M T, Kwan JTC, Williams DM, Leigh IM, et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994;78:718-26.
8. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-21.
9. Seymour RA, Thomason JM, Nolan A. Oral lesions in organ transplant patients. J Oral Pathol Med 1997;26:297-304.
10. Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scanding JD. Postransplant lymphoproliferative disorders and Epstein-Barr virus prophylaxis. Transplantation 1995;59:135-55.
11. Maxymiw WG, Wood RE, Lee L. Primary, multi-focal, non-Hodgkin's lymphoma of the jaws presenting as periodontal disease in a renal transplant patient. Int J Oral Maxillofac Surg 1991;20:69-70.
12. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesion in HIV infection. J Oral Pathol Med 1993;22:289-91.
13. Pernu HE, Pernu LMH, Huttunen KRH, Nieminen PA, Knuuttila MLE. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-53.
14. Genco RJ, Goldman HM, Cohen DW. Periodoncia. México: McGraw-Hill; 1993.
15. Tyldesley WR, Rotter E, Sells RA. Bacterial thrush-like lesions of the mouth in renal transplant patients. Lancet 1977;1:485-6.
16. Hong-Seop K, Sung-Woo L, Sung-Chang Ch, Young-Ku K. Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:316-9.
17. Avcu N, Kanli A. The prevalence of tongue lesions in 5150 Turkish dental outpatients. Oral Dis 2003;9:188-95.
18. Oksala E. Factors predisposing to oral yeast infections. Acta Odontol Scand 1990;48:71-4.
19. Nikoskelainen J. Oral infections related to radiation and therapy immunosuppressive. J Clin Periodontal 1990;17:504-7.
20. Al-Mohaya MA, Darwazeh A, Al-Khudair W. Oral fungal colonization and oral candidiasis in renal transplant patients. The relationship to Miswak use. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:455-60.
21. Campo J, Del Romero J, Castilla J, García S, Rodríguez C, Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med 2002;31:5-10.
22. Guggenheimer J, Moore PA, Rossie K, Myers D, Mongelluzzo, Block HM et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies. II Prevalence and characteristics of Candida and candidal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89;570-6.
23. Molina D, Monroy RE, Arenas R, Fernández RF, Rubalcaba PJ, Fabian SMG. Frecuencia de candidiasis oral en pacientes diabéticos tipo 2 ambulatorios en el Hospital General Manuel Gea González. Estudio clínico micológico. Dermatología Rev Mex 2002;46:3-9.
24. Ramirez-A V, Silverman S, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:149-53.
25. Redding SW, Zellars RC, Kirkpatrick WR, McAtee RK, Caceres MA, Fotherrgill AW, et al. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol. 1999;37:3896-900.
26. Ramírez-AV, Esquivel PL, Irigoyen CE, Anaya SG, González RI. Asociación de lesiones bucales con el estado serológico para el VIH. Salud Publica Mex 2002;44:87-91.
27. Greenberg MS, Cohen G. Oral infection in immunosuppressed renal transplant patients. Oral Surg 1977;43:879-85.
28. Gupta KL, Ghosh AK, Kochhar R, Jha V, Chakrabarti A, Sakhuja V. Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols. Am J Gastroenterol 1994;89:1062-5.
29. De Souza YG, Greenspan D, Felton JR, Hartzog GA, Hammer M, Greenspan JS. Localization of Epstein-Barr virus DNA in the epithelial cells of oral hairy leukoplakia by in situ hybridization on tissue sections. N Engl J Med 1989;320:1559-60.
30. Glick M, Muzka BC, Lurie D, Salkin LM. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-9.
31. Syrjanen S, Laine P, Happonen R-P, Niemelä M. Oral hairy leukoplakia is not a specific sign of HIV infection but related to immunosuppression in general. J Oral Pathol Med 1989;18:28-31.
32. Macleod RI, Long L Qi, Soames JV. Oral hairy leukoplakia in an HIV-negative renal transplant patient. Br Dent J 1990;169:208-9.
33. Greenspan D, Greenspan JS, De Souza YG, Levy JA, Ungar AM. Oral hairy leukoplakia in a HIV-negative renal transplant recipient. J Oral Pathol Med 1989;18:32-4.
34. Kanitakis J, Euvrard S, Lefrancois N, Hermier C, Thivolet J. Oral hairy leukoplakia in a HIV-negative renal graft recipient. Br J Dermatol 1991;124: 483-6.
35. Blomgren J, Bäck H. Oral hairy leukoplakia in a patient with multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Endod 1996;82:408-10.
36. Nicolatou O, Nikolatos G, Fisfis M, Belegrati M, Papadaki T, Oikonomaki E, et al. Oral hairy leukoplakia in a patient with acute lymphocytic leukemia. Oral Dis 1999;5:76-9.
37. Eisenberg E, Krutchkoff D, Yamase H. Incidental oral hairy leukoplakia in immunocompetent persons. Oral Surg Oral Med Oral Pathol 1992;74:332-3.
38. Felix DH, Watret K, Wray D, Southam J C. Hairy leukoplakia in a HIV-negative nonimmunosuppressed patient. Oral Surg Oral Med Oral Pathol 1992;74:563-6.
39. Lozada-Nur F, Robinson J, Regezi JA. Oral hairy leukoplakia in nonimmunosuppressed patients. Report of four cases. Oral Surg Oral Med Oral Pathol 1994;78:599-602.
40. Zakrzewska JM, Aly Z, Speight PM. Oral hairy leukoplakia in a HIV-negative asthmatic patient on systemic steroids. J Oral Pathol Med 1995;24:282-4.
41. Dias EP, Rocha ML, Silva Junior A, Spyrides KS, Ferreira SM, Polignano GA et al. Oral hairy leukoplakia. Histopatologic and cytophatologic features of a subclinical phase. Am J Clin Pathol 2000;114:395-401.
42. Casiglia J, Woo S-B. Oral hairy leukoplakia as an early indicator of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. J Oral Maxillofac Surg 2002;60:948-50.
43. Epstein JB, Sherlock Ch, Wolber RA. Hairy leukoplakia after bone marrow transplantation. Oral Surg Oral Med Oral Pathol 1993;75:690-5.
44. Ammatuna P, Capone F, Giambelluca D, Pizzo I, D'Allia G, Margiotta V. Detection of Epstein-Barr virus (EBV) DNA and antigens in oral mucosa of renal transplant patients without clinical evidence of hairy leukoplakia (OHL). J Oral Pathol Med 1998;27:420-7.
45. Ammatuna P, Campisi G, Giovannelli L, Giambelluca D, Alaimo C, Mancuso S, et al. Presence of Epstein-Barr virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV- infected and renal transplant patients. Oral Dis 2001;7:34-40.
46. Somacarrera ML, Hernández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-5.
47. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11
48. Spratt H, Bommer S, Irwin CR, Marley JJ, James JA, Maxwell P, et al. Cyclosporin associated gingival overgrowth in renal transplant recipients. Oral Dis 1999;5:27-31.
49. King G, Fullinfaw R, Higgins TJ, Walker RG, Francis DMA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993;20:286-93.
50. Thomason JM, Kelly P, Seymour RA. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996;23:367-71.
51. Seymour RA, Ellis JS, Thomanson JM. Risk factors for drugs-induced gingival overgrowth. J Clin Periodontol 2000;27:217-23.
52. Mc Gaw T, Lam S, Coates J. Cyclosporin-induced overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-7.
53. Hamid AK, Einollahi B, Ansari G, Bagher MM. The effect of cyclosporine with and without nifedipine on gingival overgrowth in renal transplant patients. J Can Dent Assoc 2003;69:236-41.
54. De la Rosa GE, Bustamante RM, Mondragón PA. El efecto del control de la placa bacteriana en la hiperplasia gingival inducida por ciclosporina-A. Reporte de dos casos. Revista de Ciencias Clinicas 2002;3:81-5.
55. Somacarrera ML, Lucas M, Scully C, Barrios C. Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients. Br Dent J 1997;183:89-94.
56. López LJ, Sabater RMM, Muñoz SJ, Rosello LLJ, Grañena BA. Evaluación y prevención de las complicaciones orales en los pacientes trasplantados de médula ósea. Estudio clínico. Med Oral 2000;5:345-54.